Head-to-head · WeighScore
Alternate Health Club vs Zealthy
The verdict
Alternate Health Club takes it — 69.8/100 to 46.7/100.
Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Alternate Health Club | Zealthy |
|---|---|---|
| WeighScore | 69.8/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #111 | #496 |
| Semaglutide | $129/mo (compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $169/mo (compounded) | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | Coverage not published | 34 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #111 · C
Strengths
- $129/month compounded semaglutide is among the cheapest in the US market
- $169/month compounded tirzepatide is competitive with established platforms
- Complimentary workout and dietary plans bundled with medication — most peers don't
- LegitScript verified
- US-licensed clinicians
Where it loses points
- Parent company / legal entity not publicly disclosed
- State of incorporation not disclosed
- Per-state availability not listed — confirm your state ships before committing
- Pharmacy partners not publicly named
- Unclear whether lab work is included
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.